Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study

Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study

Abstract Background The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographi...

Full description

Bibliographic Details
Main Authors:	Kenneth Bentum Otabil, María-Gloria Basáñez, Blessing Ankrah, Emmanuel John Bart-Plange, Theophilus Nti Babae, Prince-Charles Kudzordzi, Vera Achiaa Darko, Abdul Sakibu Raji, Lydia Datsa, Andrews Agyapong Boakye, Michael Tawiah Yeboah, Joseph Nelson Siewe Fodjo, Henk D. F. H. Schallig, Robert Colebunders
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Series:	BMC Infectious Diseases
Subjects:	Onchocerciasis Ivermectin Mass drug administration Non-adherence Mixed-methods Ghana
Online Access:	https://doi.org/10.1186/s12879-023-08806-8

Similar Items

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023-08-01)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
by: Robert Colebunders, et al.
Published: (2022-03-01)

Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2019-05-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-08-01)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
by: Robert Colebunders, et al.
Published: (2019-10-01)

Epilepsy in the onchocerciasis endemic area of Deim Zubeir, South Sudan: a household survey
by: Jurel Payii Mamur, et al.
Published: (2025-02-01)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
by: Alfred Dusabimana, et al.
Published: (2022-02-01)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
by: Charlotte Boullé, et al.
Published: (2019-03-01)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
by: Michel Mandro, et al.
Published: (2020-03-01)

Onchocerciasis: the beginning of the end?
by: Adrian Hopkins
Published: (2019-02-01)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
by: Alfred Dusabimana, et al.
Published: (2020-10-01)

Epidemiology of epilepsy in Wulu County, an onchocerciasis-endemic area in South Sudan
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2024-09-01)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
by: Nolbert Gumisiriza, et al.
Published: (2020-03-01)

Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
by: Robert Colebunders, et al.
Published: (2024-01-01)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-02-01)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
by: Sarah O’Neill, et al.
Published: (2019-05-01)

The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South Sudan
by: Sube KL, et al.
Published: (2024-12-01)

The Role of the Maridi Dam in Causing an Onchocerciasis-Associated Epilepsy Epidemic in Maridi, South Sudan: An Epidemiological, Sociological, and Entomological Study
by: T. L. Lakwo, et al.
Published: (2020-04-01)

Biting rates and relative abundance of Simulium flies under different climatic conditions in an onchocerciasis endemic community in Ghana
by: Kenneth Bentum Otabil, et al.
Published: (2020-05-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
by: Ed Cupp, et al.
Published: (2019-07-01)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
by: Housseini Dolo, et al.
Published: (2018-12-01)

Focus of Ongoing Onchocerciasis Transmission Close to Bangui, Central African Republic
by: Eric de Smet, et al.
Published: (2020-04-01)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
by: Melissa Krizia Vieri, et al.
Published: (2021-06-01)

Rapid diagnostic testing for onchocerciasis in Maridi (South Sudan) before and after improving elimination strategies: a repeated cross-sectional survey [version 2; peer review: 1 approved, 2 approved with reservations]
by: Amber Hadermann, et al.
Published: (2024-03-01)

Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach
by: Carabin Hélène, et al.
Published: (2003-01-01)

Ivermectin therapy for onchocerciasis: Effect on some haematological and biochemical parameters
by: E N Shu, et al.
Published: (2008-01-01)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with <i>Onchocerca volvulus</i>
by: Alfred Dusabimana, et al.
Published: (2020-12-01)

Onchocerciasis in the forest-savannah mosaic area of Nigeria
by: C P Chijioke, et al.
Published: (1998-01-01)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019-01-01)

Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on Onchocerca volvulus [version 2; peer review: 2 approved]
by: Robert Colebunders, et al.
Published: (2023-12-01)

Information for onchocerciasis control
by: Adrian Hopkins
Published: (2010-12-01)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
by: Wilma A. Stolk, et al.
Published: (2015-10-01)

Psycho-social and Economic Evaluation of Onchocerciasis: A Literature Review
by: Laura Moya Alonso, et al.
Published: (2009-02-01)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018-12-01)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
by: Melissa Krizia Vieri, et al.
Published: (2021-03-01)

Onchocerciasis in Ecuador: the situation in 1989
by: Ronald H. Guderian, et al.
Published: (1992-09-01)

Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia
by: Adugna Endale, et al.
Published: (2015-02-01)

The need for evidence-based strategies and tools for onchocerciasis elimination in Africa
by: Yankum Dadzie, et al.
Published: (2019-07-01)